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Abstract 
Prescription stimulants have been identified as one of the most written psychoactive prescription 
medications found among college students.  Likewise, prescription stimulant abuse (PSA) has 
greatly increased in the college campuses (5.4% in 2003 to 9.3% in 2013).  Several factors such 
as (a) diversion and sharing of prescribed stimulants among families, friends and others; (b) lack 
of knowledge about the risks associated with prescription stimulants; (c) polysubstance use; (c) 
academic enhancement; and (d) stress from ineffective coping skills and life events, have been 
identified as contributing factors to the increase in PSA among college students.  Various critical 
health-related symptoms such as tachycardia, hypertension, hallucinations, loss of concentrations 
and depression have been identified with PSA.  College students with prescription stimulants 
need to be aware of the associated risks identified with prescription stimulants.  In addition, 
healthcare providers caring for college students who necessitate prescription stimulants need to 
be familiar with substance abuse prevention efforts to manage PSA.  Although, numerous 
interventions have been implemented to reduce prescription drug abuse in general.  However, 
there is lack of evidence-based recommendations for the management of PSA among college 
students.  Therefore, the purpose of this project was to develop evidenced-based 
recommendations for healthcare providers to manage PSA among college students.   
Recommendations were developed after a comprehensive literature review.  Based on the 
evidences retrieved from the reviewed literature: increase in awareness and education pertaining 
to prescription stimulant, collaboration approach between healthcare providers, community, 
family and development of spiritual competence have been suggested for healthcare providers 
caring for college students with prescription stimulant.  In addition, healthcare providers are 
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encouraged to utilize these recommendations as a guiding tool when caring for college students 
with ADHD or with potential for prescription stimulant abuse.   
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Chapter 1: Introduction and Literature Review 
 
Introduction 
The prevalence in prescription stimulants for nonmedical use among college students has 
rapidly increased since 2003 (from 5.4% in 2003 to 9.3% in 2013) (Cutler, 2014; McCabe, West, 
Teter et al., 2014; Teter, McCabe, LaGrange, Cranford, & Boyd, 2006).  Stimulants have been 
identified as one of the main written psychoactive prescriptions among college students (4% in 
1991 to 45% in 2010) (McCabe, West, Teter et al., 2014; Teter, Mcabe et al., 2005).  The 
increase in PSA among college students have been associated with several critical health-related 
adverse effects (Buckstein, 2014: Substance Abuse and Mental Health Services Administration: 
SAMHSA, 2014: Helseth, Lykke-Enger, Johnsen, & Waal, 2009).  Examples of contributing 
factors to PSA among college students are diversion and sharing with friends, family and others, 
lack of awareness of the dangers involving prescription stimulant, polysubstance use and stress 
(Barrett, Darredeau, Pihl, 2006; Herman, Shtayermman, Aksnes, Anzalone, Cormerais, & 
Liodice, 2011; McCabe, Teter, Boyd, 2006).  However, there is a lack of evidence-based 
recommendations for managing PSA among college students.  Therefore, the purpose of this 
project was to develop evidenced-based recommendations for healthcare providers to manage 
PSA among college students.  
Literature Review 
Several studies have shown stimulants such as Amphetamine-dextroamphetamine 
combination agent (Adderall) and Methylphenidate (Ritalin) as one of the most written 
psychoactive prescriptions among college students (Arria & Dupont, 2010; Baldwin, Johnson, 
Gotz, Wayment & Elwell, 2006; Herman et al., 2011; McCabe, West, Teter et al, 2014; Weyandt 
et al., 2014).  The overall rate at which stimulants are prescribed for young adults in the United 
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States increased from 4% in 1991 to 45% in 2010 (Akici et al., 2013; Arria &Dupont, 
2010; Drug Abuse Warning Network (DAWN), 2011; National Institute of Drug Abuse (NIDA), 
2012; World Drug Report, 2014).  The result of a drug use study from a national perspective 
revealed that over one million prescription stimulants was issued to over fifty-four thousand 
persons in Denmark between 1 January1995 and 30 September 2011 (Pottegård, Bjerregaard, 
Glintborg, Kortegaard, Hallas, & Moreno, 2013).  Likewise, the estimated lifetime and past- year 
prevalence of nonmedical use of prescription stimulants increased significantly between 2003 
and 2013.  McCabe, West, Teter et al. (2014) found that the past year illegal use of stimulants 
among college students has significantly increased from 5.4% in 2003 to 9.3% in 2013 
(p<0.001).  On the contrary, the estimated lifetime and past-year occurrence of nonmedical use 
of prescription opioids has considerably decreased over time (9.3% in 2003 to 4.5% in 2013) 
(McCabe, West, Teter et al., 2014).  In addition, DeSantis, Noar, & Webb (2010) reported 
between 4.1% to 35.5% variability in the rate of prescription stimulant use among college 
students.  The survey conducted by Herman and colleagues (2011) reveals that about 10.4% of 
the medical and health profession students have either used stimulants or are currently engaging 
in an illegal use of prescription stimulants.  In fact, the national survey result from monitoring 
the future revealed Adderall as the most use of prescription stimulants among college students 
(Johnston, O'Malley & Bachman, 2013).  The results showed “Adderall was used more than 
three times as many college students (10.7%) as was Ritalin (3.6%) in 2013” (p.380). 
Furthermore, amphetamine use among college students has increased from 5.7% in 2008 to 
11.1% in 2011 (Johnston et al., 2013).  Although, a slight decrease was noted in 2013 (10.6%), 
the percentage continues to place college students in the highest of prescription stimulants use 
for improving academic performance than 12th graders (6.6%) (Johnston et al., 2013).     
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Factors Contributing to PSA 
           There are various factors reported to have contributed to the prevalence of PSA among 
college students. The following three key contributing factors will be discussed in this literature 
review: diversion and sharing of prescription stimulants, lack of awareness of the dangers of 
prescription stimulants, and stress resulting from changes in life events.  
 Diversion and sharing.  The increase in prescription stimulants for medical use has been 
reported to have concomitantly augmented the increase in prescription stimulant for nonmedical 
use (American College Health Association, 2014; Barrett, Darredeau, Bordy, & Pihl, 2005; 
Baldwin et al, 2006; Gomes, Song, Godwin, & Toriello, 2011; Hauer, 2010; Judson & Langdon, 
2009; Low & Gendaszek, 2002; McCabe, Knight, Teter, & Wechsler, 2005; McCabe, West Teter 
et al., 2014).  The increase in percentage of prescription stimulants for medical use such as to 
treat the symptoms of attention-deficit hyperactivity disorder (ADHD) in college students 
increases from 1.9% in 2003 to 4.7% in 2013.  Concurrently, the percentage of nonmedical use 
of prescription stimulants such as the diversion of the prescribed stimulants to friends and family 
appears to have increased from 5.4% in 2003 to 9.3% in 2014 (McCabe, West, Teter et al., 
2014).  McCabe, West, Teter et al. (2014) reported the following findings from the College 
Student Life Survey (CSLS) conducted in the winter semester of 2003 through 2013 among 
undergraduate population of full time college students of a public research university:   
• Prescription stimulants are the most diverted and shared prescription medication among 
college students.   
• There is increase in prescription stimulants and prescription stimulants diversion (selling, 
trading, or giving away) among college students.   
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• About 54-percent undergraduate students with prescription stimulants for medical use 
have shared, sold or gave away the prescribed stimulants to family or friends.  
While the CSLS result revealed a decrease in diversion rate of stimulants from 53.0% to 
46.2%, the percentage that represents the decrease in diversion rate of prescription stimulants 
(46.2%) is higher than the percentage that represents diversion rate of other psychoactive drugs 
such as “sleeping medication” (18.9%), “sedative or anxiety medication” (22.2%), “pain 
medication”  (14.4%) ( McCabe,West et al., 2014).  Moreover, the opportunity for being offered 
prescription stimulants and PSA have been associated with age and year spent in the college 
campus (DeSantis, Noar et al., 2010).  A study by Garnier-Dykstra, Caldeira, Vincent, O’Grady 
& Arria (2012) also showed the opportunity for being offered prescription stimulant and PSA 
increases from 36.0% in the first year in college to about two-thirds (61.8-percent) by the end of 
forth year in college.  This result shows (a) there is a chance of being exposed to prescription 
stimulants in the college campuses; (b) college students with prescription stimulants have a habit 
of sharing or diverting their prescription stimulants to friends and others without the 
authorization of their healthcare providers and; (c) college students who are being offered 
prescription stimulants have tendency to abuse or misuse the prescription stimulants.   
 Lack of awareness concerning the dangers of prescription stimulants.  According to 
Kuhar (2014), prescription stimulants have been accepted as non-dangerous as long as they are 
dispensed as ordered, used as prescribed, and closely monitored by licensed professionals.  
Several research articles have described methylphenidate (MPH) and amphetamines as highly 
effective pharmacological  management of ADHD (Baldwin et al., 2006; Barrett, Darredeau, 
Bordy et al., 2005; Bukstein, 2014; Cutler, 2014; Judson & Langdon, 2009; Low & Gendaszek, 
2002; Mészáros, Czobor, Bálint, Komlósi, Simon, & Bitter, 2009; Teter, McCabe, Cranford, 
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Boyd, & Guthrie, 2005; McCabe, Knight, Teter et al, 2005; McCabe, Teter, Boyd et al., 2006; 
Weyandt et al. 2014).  Furthermore, the high effectiveness of prescription stimulants in the 
management of ADHD has made them acceptable as the first line pharmacological agents for 
treating the symptoms of ADHD (American College Health Association, 2014; Baverstock & 
Finlay, 2003; Bukstein, 2014; Cutler, 2014; Krull, 2014; Weyandt, et al., 2014).  A meta-analysis 
of six short-term clinical trials comparing stimulant medication with placebo in adults with 
ADHD shows patients receiving the stimulant experienced greater improvement in ADHD 
symptoms compared with placebo, with an estimated effect size in the medium-to-high range 
(Cohen’s d = 0.67, p<0.0001 vs. placebo) (Mészáros et al., 2009).  Therefore, the United States 
Food and Drug Administration (FDA) has approved the efficacy of stimulant medication for the 
treatment of ADHD (Spencer, Biederman, Wilens, 1998 as cited in Weyandt et al., 2014).  
 Furthermore, several studies have disclosed most college students who abuse prescription 
stimulants perceived stimulants to be more appropriate than the street drugs because they are 
usually prescribed by licensed professionals (DeSantis, Noar et al., 2010; Cutler, 2014; Gomes et 
al., 2011; McCabe et al., 2008; Teter, McCabe et al., 2005).  Cutler (2014) reported college 
students’ perception of prescription stimulants “as opposed to illegal stimulants (such as cocaine 
and methamphetamine) as “safer” choices for experimentation and getting high because they 
have been approved by the Food and Drug Administration (FDA) and are “pure,” having known 
chemical compositions and predictable side effects” (p.278).  The result of the semi-structured 
interviews conducted between 2010 and 2011 academic year among seventy-six college students 
from a large, public northwestern university documented ‘safety’ as one of the major reasons for 
PSA among college students (Cutler, 2014).  In addition, the study conducted by Arria, Caldeira, 
Vincent, O’Grady & Wish (2008) also revealed one out of four students perceived increased risk 
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of harm from occasional PSA (25.2%).  Therefore, high perceived harmfulness was associated 
with lower PSA (p < 0.05).  These scholars revealed individuals who perceived “no risk” in PSA 
as the most likely to use stimulants (b=3.4, p<0.01), followed by those whose perceived risk was 
“slight” (b=2.8, p<0.01) or “moderate” (b=0.9, p=0.11).       
 On the other hand, stimulants are recognized as potentially addictive chemical substances 
(Barrett, Darredeau, Bordy et al., 2005; Bukstein, 2014).  The addictive characteristics of CNS 
stimulants may lead to dependency that could ultimately affect the overall wellbeing of a person 
including the mental, emotional, physical, occupational, intellectual, and spiritual aspects (Chen, 
2006; Chidarikire, 2012; Helseth, Lykke-Enger, Johnsen, & Waal, 2009; SAMHSA, 2013).  
Moreover, the rate of addiction or dependency among individuals with medical use for ADHD 
treatment has not been well established (Bukstein, 2014).  However, the later the age of initiation 
of prescription stimulant the lower the tendency for prescription stimulant addiction.  Individuals 
who started using prescription medication at age 13 were found to have developed prescription 
drug abuse and dependence versus those individuals who began using at or after 21 years of age 
(McCabe, West, Morales, Cranford, & Boyd (2007). The probabilities of developing any lifetime 
prescription drug abuse among non-medical users was reduced by approximately 5% with each 
year the non-medical use was delayed (McCabe, West, Morales et al., 2007).  In addition, the 
effects of prescription stimulants abuse on the cardiovascular system remain controversial.  For 
example, Habel et al. (2011) research study showed no associated risk of prescription stimulants 
on the cardiovascular system among young and middle-aged adults.  A non-randomized cohort 
study conducted among 18 years and older with methylphenidate prescription revealed a lack of 
a dose-response relationship (Schelleman et al., 2012).  The result of the study revealed the age-
standardized incidence rate per 1,000 person-years of sudden death or ventricular arrhythmia was 
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2.17 (95% CI=1.63-2.83) in methylphenidate users and 0.98 (95% CI=0.89-1.08) in nonusers, for 
an adjusted hazard ratio of 1.84 (95% CI=1.33-2.55) (2012).  This result showed the dose of 
methylphenidate is inversely related to the risk experienced by an individual.  For this reason, the 
authors concluded there may be no causal relationship between methylphenidate and 
cardiovascular side effects.  Even if a 1.8 fold increase in the risk of sudden death or ventricular 
arrhythmia was reported in young and middle adult at the initiation of methylphenidate 
(Schelleman et al., 2012).  Similarly, some studies have reported prescription stimulant use 
without the supervision of licensed health care providers is associated with cardiovascular, 
psychological, spiritual, and mental adverse effects such as cardiac arrhythmias, tachycardia, 
hypertension, syncope, hopelessness, psychosis, depression (Bukstein, 2014; Helseth, Lykke-
Enger, Johnsen & Waal, 2009; McCabe, & Teter, 2007; NIDA, 2012; Ruwald, Ruwald, & 
Tønder, 2012; SAMHSA, 2013; Schelleman et al., 2012; Stiefel & Besag, 2010 as cited in 
Martinez-Raga, Knecht, Szerman, & Martinez, 2013; Teter, Falone, Cranford, Boyd, & McCabe, 
2010;Volkow, 2010.  The meta- analysis randomized clinical trials conducted by Castells, Cunill, 
Capellà (2013) showed the use of methylphenidate for the treatment of ADHD symptoms was 
discontinued among ten percent adult because of the adverse effects experienced during 
treatment.  Other identified mild to moderate adverse effects associated with prescription 
stimulants are dry mouth, insomnia, restlessness, irritability, dysphoria, loss of appetite, weight 
loss, depression, headaches and potential for sudden cardiac death  (Bukstein, 2014; Castells et 
al., 2013; Martinez-Raga et al., 20I3; Teter, Falone et al., 2010).  Depressed moods have been 
recognized in about 30 percent college students who frequently abuse prescription stimulants 
(Teter, Falone et al., 2010).  Some other identified side effects are the exacerbation of existing 
motor and vocal tics as well as new onset of tics, amphetamine-induced psychosis, and 
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schizophrenia disorder (Bukstein, 2014; Bramness, et al., 2012).  Therefore, prescription 
stimulant is not safe because they have a potential addictive effects and the addictive 
characteristics may potentially affect the overall well-being and lead to sudden death  
 Additionally, Baldwin and colleagues (2006) conducted a needs/assets assessment survey 
on college campuses using six focus groups, with a total of 45 undergraduate college students 
from various majors.  The college students generated a list of 25 substances used in the college 
campuses and reported to divert these drugs for nonmedical uses.  The report of this survey also 
revealed college students fake medical conditions to obtain prescription for methylphenidate or 
other prescription stimulants for the following reasons such as for recreational use, mixing with 
alcohol to achieve “high” and for financial purpose.  The results of the survey also indicated that 
the students were not adequately educated on the adverse effects associated with the prescription 
stimulants abuse.  At the same time, the researchers discovered that the healthcare providers in 
the college campuses were not cognizant of the variety of substances used among students and 
the ways the students obtain these substances.  These results not only highlight the importance of 
further education to raise awareness, but also stress the value of team approach (students, faculty 
and health-care providers) in preventing substance abuse in college campuses.     
 Moreover, some studies have shown the relationship between prescription stimulant 
abuse and other controlled substances such as alcohol and other psychoactive drugs (Arria et al., 
2008; Arria & Dupont, 2010; Barrett, Darredeau, Bordy et al., 2005; Barrett, Darredeau Pihl, 
2006; DeSantis, Noar et al., 2010; Johnston et al., 2013; Judson & Langdon, 2009; McCabe, 
Knight, Teter et al., 2005; ;  McCabe, Teter, Boyd et al, 2006; McCabe, West, Morales, 
Cranford, & Boyd, 2007; McCabe, West, Teter et al, 2014; Teter, McCabe et al., 2005).  The 
result of Barrett and colleagues’ (2006) study showed “those who misused MPH were more 
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likely to have used various other prescriptions and nonprescription stimulant drugs over their 
lifetimes.”  In this study, those who abuse MPH agreed to recreationally utilize other variety of 
substances during their lifetimes (mean 7.7, SD 3.0) relative to control subjects (mean 3.8, SD 
3.1) {t = 5.98, df 98, P < 0.001).  Moreover, the Chi-square tests also showed that MPH users 
were more likely to report recreational use of ecstasy, cocaine, ephedrine, d-amphetamine, and 
psilocybin (all Ps < 0.001) than were control subjects (Barrett 2005. P. 458).  These results show 
that college students are not fully aware of the danger of the use of prescription stimulants 
including potential for poly-substance abuse.    
Stress.  Another factor identified with the increase in PSA among college students is stress 
(Herman et al., 2011).  Freshmen college students face challenges from new responsibilities, new 
curriculum, and higher expectations that are different from high school settings (Herman et al., 
2011; Teter, Falone et al., 2010).  The workload of college, meeting deadlines, keeping up with 
social lives, and waiting to the end of the semesters to study for final examinations are some of 
the stressors identified with college students (Macan, Shahani, Dipboye, & Phillips, 1990; 
Alzayyat, & Al-Gamal, 2014).  The fear of failure and anxiety as a result of change in curriculum 
reported among college students are encouraging prescription stimulant abuse (Desantis, Noar et 
al, 2010; Garnier-Dykstra et al., 2012; Gomes et al., 2011; Teter, Falone et al., 2010).  However, 
college students who are able to cope effectively and manage their new environment with change 
in academic and social lifestyles have shown improvement in academic performances (Forbus, 
John, & Sanjay, 2010; Kearns & Gardiner, 2007; Macan et al., 1990).  DeSantis, Webb, & Noar 
(2008), survey shows most students who are unable to cope with the workload of college use 
stimulants for academic performance enhancement.  Most college students reported the reason 
for engaging in prescription stimulant was to improve their grade point average (GPA) (a 
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measure of academic performances) (Garnier-Dykstra et al., 2012).  DeSantis, Webb et al. (2008) 
study also revealed about 65-percent of students using Adderall to enhance concentrations, 59.8 
percent students use Adderall to study, and 47.5-percent use Adderall for increase alertness to 
study longer.  Among all the motives, studying was identified by most college students as the 
predominant purpose of engaging in prescription stimulant abuse (73-percent to 91.5-percent 
annually) (Garnier-Dykstra et al., 2012).         
 On the contrary, the use of prescription stimulant has been reported to have no 
relationship with increasing the GPA.  Those who abuse prescription stimulants have been 
reported to have lower GPAs when compared to non-users (DeSantis, Noar et al., 2010).  The 
result of the questionnaires administered by Advokat, Lane, & Luo (2011) to a total of 92 
students with a self-reported diagnosis of ADHD who use prescription stimulants for ADHD 
symptoms management was compared with 143 controlled students in a survey of academic 
performance.  The result showed the GPA of the ADHD students who took the medications was 
still significantly lower than the control group GPA (p = .022).   McCabe, Knight, Teter et al. 
(2005)  mail survey result also showed students who received a B or lower GPA were almost two 
times more likely to report prescription stimulant abuse (5.2% (95% CI= 4.2, 6.5) compared to 
students who earned a B+ or higher (3.3% ( 95% CI= 2.6, 4.1). 
Interventions For Decreasing Substance Abuse Among College Students    
 The risk for polysubstance use increases among college students who engage in any kind 
of substance abuse (Barrett, Darredeau, Pihl, 2006; DeSantis, Noar et al., 2010; Johnston et al., 
2013; Teter, McCabe et al., 2005; NIDA, 1995).  Therefore, most interventions are specifically 
developed to address substance abuse in general.  These interventions can be grouped into three 
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categories such as the ecological, or environmental approach, the group-centered approach, and 
the individual-centered approach (Baldwin et al., 2006). 
The ecological or environmental approaches.  These approaches focus on the 
institution, community and public policy level in relation to physical and social environment 
(Baldwin et al., 2006; DeJong, Gomberg, Towvim, & Schneider, 2007; Kann, Telljohann, & 
Wooley, 2007).  The ecological approaches proposed that young people’s decision to abuse a 
substance is fashioned by a “complex combinations of physical, social, economic, and legal 
factors.”  These combinations also have a great impact on the substance’s demand and 
accessibility (DeJong ett al., 2007, p.231).  Therefore, the objective of these preventive strategies 
is to adjust the physical and social environment in the reduction of substance abuse in the 
community including college campuses.  For example, DeJong and the colleagues (2007) 
developed 12 policies and enforcement strategies to reduce alcohol problems on campuses.  The 
researchers used a random sample of 9,600 students from 32 four-year colleges and universities.  
A voluntary, anonymous email survey was administered to assess the students’ alcohol-related 
attitudes, perceptions, behaviors and their supports for the alcohol policies and enforcement 
strategies.  The results showed that the majority of the students at all 32 schools supported 
stricter enforcement policies and penalties to maintain a safe and substance-free campus.  Saltz 
and DeJong (2002) also concluded that modifying the environment through institution, 
community, and public policy changes are the most resource-efficient way of reducing substance 
abuse problems.           
 Furthermore, several studies have shown the effectiveness of school-based intervention 
programs on prevention of substance abuse among students.  For example, programs which 
facilitate (a) growth awareness and resistance skills such as messages from media, normative 
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education, resistance to peer influences, and emphasis on healthy behavior;  (b) personal efficacy 
and social skills such as decision-making, coping and stress management, and communication; 
and (c) effective components such as improving self-esteem have demonstrated positive effects 
in reducing the amount of illegal drug found among students (Champion, Newton, Barrett, & 
Teesson, 2013; Kann, Telljohann, & Wooley, 2007 as cited in Kumar,  O'Malley, Johnston, & 
Laetz, 2013).  In general, these approaches empowered students, staff, and faculty with 
leadership skills to promote policies and plans against all kinds of substance abuse, permit 
students to embrace positive values and promote a beter social interaction among students and 
faculty (Bucknam, 1994; DeJong et al., 2007).        
 The group-centered approaches.  The objectives of the group-centered approaches in 
the prevention of substance abuse focus on the relationship between students and their 
perceptions concerning drinking standards on college campuses (DeJong & Langford, 2002).  
These approaches allow for strategic planning of different levels of interventions to specifically 
reduce the abuse of alcohol among college students (DeJong et al., 2002).  One of the 
interventions suggested is the implementation of social norms campaign.  Social norms is viewed 
as perceiving a certain behavior such as the episodic drinking in the college campuses as normal 
(Moreira, Smith & Foxcroft, 2009).  A study by Matten & Neighbours (2005) revealed a 
correlation between promotions of social norms campaigns and changes in perceived drinking 
norms. The paired samples t-tests of the study disclosed a reduction in perceptions of individual 
college student drinking occurrence and amount.  The result of the study shows a reduction in the 
drinking level of alcohol when the idea surrounding drinking in the colege campuses was 
promoted as abnormal and unacceptable.  However, the reduction in drinking level was noticed 
only among the students who perceived episodic drinking was normal in the college campus.  
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The implementation of social norms has shown a changing effect on students’ perceptions of 
drinking norms which reduces levels of drinking among college students (Matten et al., 2004).  
 The individual-centered approaches.  These approaches include a brief intervention 
(BI)/ brief motivational intervention (BMI), feedback, provider screening, and mailed feedback 
on the possible consequences related to substance abuse (Baldwin et al., 2006; Fachini, Aliane, 
Martinez & Furtado, 2012; Larimer & Cronce, 2007).  The purpose of the individual-centered 
approach is to provide education/awareness and early screening to detect alcohol abuse and its 
related harmful consequences among college students (Fachini et al., 2012; Larimer et al. 2007).  
For this reason, the approaches include early identification, education, prevention, treatment with 
professional advice and feedback.  The conclusion of the literature review on the effectiveness of 
the individual-focused college drinking prevention strategies conducted from 1999-2006 by 
Larimer and colleagues (2007) revealed BMI as effective method for the individual who wants to 
quit or not yet dependent on a controlled substance.  The individual-centered approaches also 
were categorized as the information/knowledge programs and the brief motivational intervention 
(BMI) programs. 
The information/knowledge programs.  The program provided “a pamphlet with 
information about risks of drinking, in which participants recorded information about their 
drinking to a wait-list control.” (Larimer et al. 2007, p. 2443).  As an education/awareness 
program, the overall conclusion of the information/knowledge programs revealed reductions in 
number of drinks per week over time, and there was no reduction in heavy episodic drinking.  
Hence, one out of ten reviewed research articles supported the information/knowledge programs. 
 The brief motivational intervention.  The purpose of the BMI program is to reduce 
extreme drinking by providing early screening and intervention to reduce the number of alcohol-
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related problems in the college campuses (Fachini et al., 2012).  Several studies have revealed a 
positive long-term effect on reduction of alcohol abuse among college students after several 
years with BI/ BMI (Fachini et al., 2012; Larimer et al., 2007; Marlatt et al., 1998 as cited in 
Baldwin, 2006).  A systematic review and meta-analysis conducted  by Fachini and colleagues 
revealed the effectiveness of BI/BMI on college students with episodic drinking.  The 
motivational intervention delivered to these college students was based on the principles of the 
Brief Alcohol Screening Intervention for College Student (BASICS) proocol.  The BASICS 
protocol includes using (a) techniques of motivational interview and personalized feedback 
based on students drinking behavior; (b) delivering face-to-face intervention which is usually 
conducted over the course of two structured sessions and (c) comparison with other conditions 
(such as control group or alternative intervention) (Fachini et al. 2012, p. 2).  The samples of the 
college student ranged from 54 to 1275 (median=212).  The review concluded students receiving 
BASICS had a significant reduction in alcohol consumption (difference between means =−1.50 
drinks per week, 95% CI: -3.24 to −0.29) and alcohol-related problems (difference between 
means =−0.87, 95% CI: -1.58 to −0.20) after approximately 12-month of follow-up compared to 
the control group.   However, the efficiency of BMI/BI in reducing other drug-related abuse in 
people not seeking help has not been well established (Hingson, & Compton, 2014; Young, 
Stevens, Galipeau, Pirie, Garritty, Singh, & Moher, 2014; Saitz, Barrio, & Miquel, 2014).  The 
meta- analysis review also shows 10 out of 14 reviewed studies support BMI.  Overall, brief 
intervention for college students utiilizing the BASICS protocol and delivered face-to-face can 
lower both alcohol consumption and negative consequences in college students.      
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Problem Statement 
The rate at which stimulants such as Amphetamine-dextroamphetamine combination 
agent (Adderall) and Methylphenidate (Ritalin) are prescribed has rapidly increased (4% in 1991 
to 45% in 2010) (Akici et al, 2013; NIDA, 2012; World Drug Report, 2014). The research 
conducted by McCabe and colleagues in 2013 and Teter and colleagues in 2006  revealed 
increase in prevalence of PSA among college students from 5.4% in 2003 to 9.3% in 2013.  The 
health related consequences associated with PSA are physical, psychological, spiritual and some 
risks taking behaviors such as polysubstance abuse (American College Health Association, 2014; 
NIDA, 2011; Arria & Dupont, 2010; Barrett, Darredeau, Bordy et al., 2005; Barrett, Darredeau, 
Pihl, 2006; Becker & Starrels, 2014; Bukstein, 2014; Castells et al., 1013; Chen, 2005). While 
several approaches have been implemented to manage substance abuse in general, there is lack 
of evidence-based recommendation for managing PSA among college students.  Therefore, the 
purpose of this project was to develop evidence-based recommendations for managing PSA 
among college students. 
 
 
 
 
 
 
 
 
 
 
 
   
 
16 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
17 
Chapter 2: Concept Analysis 
The concept analyzed in this chapter is prescription stimulant abuse. The method of 
concept analysis by Walker & Avant (1985) was used for the analysis.  
Definitions 
Stimulants  
Stimulants are one of the classes of psychoactive drugs that act to alter the activities in 
the brain (Bukstein, 2014).  According to Bukstein, stimulant ingestion increases the 
“intrasynaptic concentrations of dopamine and norepinephrine” in the brain (2014).  Dopamine 
and norepinephrine are among the neurotransmitters found in the brain and assist in the 
conduction of signals in the brain and other vital areas (Mandal, 2013; McCance & Huether, 
2010.p. 448, 2010).  These neurotransmitters act as “chemical messengers”.  The effect of 
dopamine and norepinephrine may be inhibitory or excitatory. The excitatory effects of synthetic 
dopamine and norepinephrine in the brain stimulate the sympathetic nerves and may produce 
some physiological symptoms such as tachycardia, hypertension, euphoria, jittering, 
hyperglycemia, and restlessness (NIDA, 2014).  The inhibitory effects of chemical messengers 
on the parasympathetic nerves may slow down most activities of the body and result in 
depression and drowsiness (Mandal, 2013; McCance et al, p. 448, 2010).  In addition, stimulants 
such as amphetamines (Adderall and Dexedrine) and MPH (Ritalin and Concerta) are classified 
as one of the schedule II drugs.  Schedule II drugs provide positive therapeutic effects, however, 
they have a significant potential for abuse (DEA.Gov. 2005 & NIDA, 2006).  Therefore, this 
class of drugs may only be used if prescribed and signed by a licensed practitioner.  A refill of 
schedule II drugs is permitted only after the patient returns to the licensed practitioner for 
additional assessment (Arcangelo & Peterson, 2013).  Furthermore, stimulants are classified as 
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long-acting with sustained release and short acting with immediate release (Bukstein, 2014).  For 
example, amphetamines are available in immediate and sustained-release formulations with an 
onset of action of 20 to 60 minutes.  The duration of methylphenidate’s clinical effect varies such 
as short-acting (3 to 5 hours); intermediate-acting (4 to 8 hours); and long-acting (8 to 12 hours).  
Moreover, the immediate-release formulation of mixed amphetamine salts has a duration of up to 
six hours and the longer-acting formulations last up to 10 hours (Daughton & Kratochvil, 2009).   
 Prescription Stimulants   
The word ‘prescription’ can be variously defined.  However, the working definition 
embraced for this project is from Aronson (2012).  The research article by Aronson (2012) 
defines prescription as an officially written instruction or message provided by a licensed 
healthcare provider for a specific condition.  In addition, the written instruction or message from 
a licensed professional will be “ balanced” if it includes a detailed information of the medicine or 
therapy, the form, frequency, dosage, route, and to whom the medication or therapy will be given 
(Aronson, 2009 & Aronson, 2012).  Prescription stimulants used as prescribed by a licensed 
health care practitioner for managing specific symptoms are simultaneously referred to as 
medical use prescription stimulants (MUPS) (Teter, McCabe et al., 2005).  Therefore, a 
prescription stimulants is referred to as “balanced” prescription when it contains information 
provided by a licensed healthcare practitioner, for a patient’s appropriate condition(s) and also 
within the therapeutic goal to provide more benefits than harm the patient (Aronson, 2009 & 
Aronson, 2012).   
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Prescription Stimulant Abuse (PSA)   
PSA is defined as unlawful use of prescription stimulants by an individual in a way that is 
not prescribed or authorized by a licensed care practitioner (Cutler, 2014; DAWN, 2011; 
Greydanus, 2014; McCabe et al, 2006; NIDA, 2014; Teter, McCabe et al., 2007, Barrett et al., 
2006; Volkow & Swanson, 2003; Volkow, 2010).  The unlawful way of obtaining and using 
prescription stimulants or PSA are also refer to as a “nonmedical use” of stimulants (NMUPS) 
(Baldwin et al., 2006; Barrett et al., 2006; Cutler, 2014; McCabe, Knight, Teter et al., 2005; 
McCabe et al, 2006; NIDA, 2014; Teter, McCabe et al., 2005; Rozenbroek & Rothstein, 2003).  
The use of prescription stimulants for an enjoyable effect such as recreational use in abundant 
quantities and getting ‘high’ is referred to as PSA or nonmedical use (Barrett et al., 2006).  The 
nonmedical users of prescription stimulants have been also known to use prescription stimulants 
via intranasal, smoking on inhalation and or intravenous (Teter, McCabe et al., 2005; Barrett et 
al., 2006).  Therefore, the prescription stimulants use in another way or route other than indicated 
by a licensed practitioner is characterized as PSA 
Defining Attributes of PSA 
The defining attributes of PSA are:      
‘Unauthorized Use’ 
The prescription stimulants (long or short acting) which are being used other than for the 
right patient, dose, frequency, route are viewed as unauthorized use (Aronson, 2009; Aronson, 
2012; Bukstein, 2014; Gunter, 2013; Judson et al., 2009; Weyandt, et al, 2014).    
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Diversion or Sharing 
The prescription stimulants that are diverted or shared with friends, family or others are 
also characterized as PSA (Ellis & Mullan, 2009; Barrett et al., 2006; Garnier-Dykstra, 2012).  
The primary source of MPH abuse has been identified as through diversion from friends or 
family with MUPS (Barriett, et al., 2006;  McCabe, West, Teter et al., 2014; Garnier-Dykstra, 
2012).    
Antecedents To PSA 
The Increase In The Prescription Of Stimulant And Diversion 
Most PSA occurs as a result of the increase in the availability of stimulants through 
written prescription and diversion to friends, family and others (American College Health 
Association, 2014; Barrett et al., 2005; Baldwin et al, 2006).  As discussed in previous chapters, 
several studies have shown stimulants such as Amphetamine-dextroamphetamine combination 
agent (Adderall) and Methylphenidate (Ritalin) as one of the most written psychoactive 
prescriptions among college students (McCabe, West, Teter et al, 2014; Akici et al, 2013; 
Baldwin et al., 2006; Herman et al., 2011; Weyandt, et al.., 2014).  Likewise, the increase in the 
prescription of stimulants among college students has paved the way for the increase in diversion 
or sharing among college students. 
Lack Of Awareness Of The Negative Impacts Of Prescription Stimulants 
Other antecedents to PSA are lack of awareness of the negative impact of prescription 
stimulants and stress (Barrett et al., 2006; Cutler, 2010; Garnier-Dykstra et al., 2012).  Most 
college students perceive prescription stimulants as safe because they are prescribed by licensed 
healthcare practitioners.  However, a study by Barrett and colleagues (2006) revealed the risk of 
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simultaneous polysubstance use among drug-using college students.  The result of the study 
indicated that most students who recreationally utilize a controlled substance have the tendency 
to engage in more than one substance such as alcohol and other psychoactive drugs (Barrett et 
al., 2006).             
 Stress 
The stressful event of college student life has been revealed to precipitate the increase of 
PSA (DeSantis, Webb et al., 2008; McCabe, West, Teter et al., 2014).  Most college students 
(73%-91%) have identified studying for good grades as one of the most reasons that precipitated 
the reason for their PSA (Garnier-Dykstra, et al., 2012).      
Consequences Of PSA 
The addictive characteristics of CNS stimulants may lead to dependency that could 
ultimately affect the overall wellbeing which includes the “mental, emotional, physical, 
occupational, intellectual, and spiritual aspects of a person's life.” (Bukstein, 2014; SAMHSA, 
2013; Chen, 2006; Chidarikire, 2012; DeSantis, Webb et al., 2008).  Studies have shown the 
relationship between prescription stimulant abuse and other controlled substances such as 
alcohol and other psychoactive drugs ( DeSantis, Webb et al., 2008; Barrett et al, 2005; Arria, et 
al., 2008; McCabe, West, Teter et al, 2014; Johnston, O'Malley, & Bachman, 2013).  
Prescription stimulants use without the supervision of licensed health care providers have been 
associated with cardiovascular adverse effects such as cardiac arrhythmias and hypertension 
(Ruwald, Ruwald, & Tønder, 2012 & Stiefel & Besag, 2010 as cited in Martinez-Raga, Knecht, 
Szerman, & Martinez, 2013).  
 
   
 
22 
Case Model 
MK was a 19-year-old male and freshman college students. He came to the outpatient 
clinic for a refill on his ADHD medication (Ritalin IR 30mg twice daily).  Ritalin was prescribed 
to MK 10 days ago, and the instruction was to have a 30 day supply from his pharmacy.  MK 
stated he had his 30-day supply but had increased his frequency of dosage from twice daily to as 
needed.  MK also stated using his medication more than three times daily due to the stressful 
events surrounding his upcoming final examination.       
 After completing the history and physical examination, MK was discovered to have given 
some of his prescribed medications to his roommate (SL) who knows MK’s health diagnosis.  
MK stated SL told him he had read on the internet the efficacy of Ritalin (a stimulant) in 
increasing concentration and time for study.  MK stated he was not sure of how many of his 
medication SL had taken but knew SL had been crushing and inhaling some medication.  MK 
also stated they both keep their medications in one medicine cabinet in the same bathroom he 
shares with his roommate.          
  In this case model, MK demonstrated some attributes of PSA such as taking prescribed 
stimulants not as authorized by his health care practitioner, using the wrong dose with the wrong 
frequency and sharing his prescribed stimulant with his roommate.  MK’s roommate (SL) also 
demonstrated the attribute of PSA by utilizing prescription stimulant without authorization and 
through the route not approved or recommended by a licensed healthcare practitioner.  
Application To The Project 
The importance of increasing awareness of PSA among college students and their 
providers is critical to the management of PSA.  College students with prescription stimulants 
need to be aware of the associated risks identified with prescription stimulants.  Similarly, health 
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care providers caring for college students who necessitate prescription stimulants need to be 
familiar with substance abuse prevention efforts to manage PSA.  Evidence-based 
recommendations for managing PSA can be used as a guiding tool for healthcare providers when 
healthcare providers provide face-to-face consultation in the primary care settings to college 
students with prescription stimulants.  In addition, collaborating with family of the college 
students with prescription stimulants and the community is very crucial to the management of 
PSA.  Therefore, the evidence-based recommendations generated from this project will be useful 
also in reminding health care providers to involve the family of college students in the 
management of their stimulant prescriptions.  
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Chapter 3: Methodology and Framework 
 
Methodology and Framework 
The IOWA Model of Evidence- Based Practice (EBP) was used to guide this evidence-
based project. The IOWA model provides a systematic approach to describing knowledge 
transformation and to guide the implementation of research into clinical practice (Titler et al., 
2001).  This model has shown effectiveness in improving health care outcomes internationally 
across a variety of practice settings (Titler et al., 2001).  Advanced practice nurses may use this 
model to identify a significant clinical problem relevant to their clinical practice, develop 
evidence-based solutions and implement the solutions to the practice setting.   
Figure 1: Seven Steps of Iowa Model of Evidence-Based Practice (EBP) 
 
 by Doody & Doody, 2011. 
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      The Iowa Model of EPB involves seven steps 1) select a topic, 2) form a team, 3) retrieve 
evidences, 4) grade evidences, 5) develop an evidence-based standard, 6) implement the 
evidence-based standard, and 7) evaluate the implementation of the evidence-based standard.  
However, this study will focus on steps one through five of the model. (See Figure 1 for Seven 
Steps of the IOWA Model) (Doody & Doody, 2011; Titler et al., 2001).  This project focuses 
only on steps one through five.   
Step One: Selection Of A Topic 
The topic of this project was selected based on the concerns expressed by various 
research articles regarding the increase in the occurrence of PSA especially among college 
students’ populations (Barrett et al., 2006;  Cutler, 2014;  McCabe et al., 2006;  McCabe, West 
Teter al., 2014; SAMHSA, 2013;  Teter, McCabe et al., 2005;  Underhill & Langdon, 2013).  As 
one of the highest priority of public health concerns, prescription stimulants such as Adderall, 
Vyvanse, concerta and Ritalin are reported as some of the most widely misused and abused than 
opiods or other psychoactive prescriptions (McCabe, West. Teter et al., 2014: NIDA 2011: 
Johnson et al., 2013).  The number and percentage of persons aged 12 and older who currently 
use methamphetamine increases in 2010 from 353,000 (0.1-percent) to 595, 000 (0.2-percent) in 
2013 (SAMHSA, 2013).  In addition, the result of the American College Health Association- 
National College Health Assessment (ACHA-NCHA II) released in the spring of 2014, reported 
10.6-percent college male and 8.0-percent college female students using prescription stimulants 
within the last 12 months (ACHA-NCHA II, 2014).  In 2009, DAWN associated about 93, 562 
emergency room visits with amphetamines and methamphetamine misuse (NIDA, 2011). 
College students who lack awareness of the dangers surrounding the abuse of prescription 
stimulant face several health consequences which can impact their total well beings.  Based on 
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this information, a close therapeutic monitoring of the prescription stimulant by healthcare 
providers and comprehensive approach of management is essential to minimize the abuse of 
prescription stimulants and reduce some health-related consequences (He, Sense, & Antshel, 
2015; McCabe, West, Teter et al., 2014).      
Step Two: Forming A Team 
The team members include a MSN capstone committee (Cedarville University, School of 
Nursing), and a healthcare provider from a local health network.  
Step Three: Evidence Retrieval   
This step involves retrieving related research evidences from educational databases to 
support the project.  The following stages were followed to retrieve evidences for this project: 
Databases.  Articles were retrieved from the following databases:  Academic Search 
Complete, Alt HealthWatch, AMED - The Allied and Complementary Medicine Database, 
CINAHL Plus with Full Text, Cochrane Database of Systematic Reviews, Health Source- 
Nursing/Academic Edition, MEDLINE with Full Text,  New Testament Abstracts, Old 
Testament Abstract, Psychology and Behavioral Sciences Collection,  and PUBMED.  
Key Terms. The following key terms used for retrieving articles from the databases are: 
prescription stimulant abuse, nonmedical prescription use, prescription abuse, ADHD, stimulant 
abuse intervention, stimulant abuse management, college health, substance abuse prevention, 
substance abuse management, prescription stimulants, PSA prevention, young adults and college 
students.  Articles were not limited to full-text articles and the University’s holdings:  Inter- 
Library Loan method was used to retrieve articles from other institutions for a comprehensive 
literature reviews.     
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 Inclusion Criteria.  The research articles were retrieved based on the following 
inclusion criteria: 1) peer-reviewed research articles from the studies conducted in the United 
States and from the international studies, 2) articles published in the last fifteen years with 
exception of classic studies on PSA and substance abuse in general, 3) articles on PSA and other 
substance abuse studies that use college students/young adults as the study participants, 4) 
practice guidelines and position statements from professional organizations such as Agency for 
Healthcare Research and Quality's (AHRQ) National Guideline Clearinghouse were included 
this project.     
Step Four And Five: Grading The Evidence and Developing EBP Recommendation  
During this phase, articles were reviewed and organized.  The strength of the research 
findings was graded.  For this project, Melnyk’s grading system was used to grade the strength of 
research evidences, and the Joanna Briggs Institute (JBI) binary grading system of 
recommendation was used to grade the evidence-base recommendations.  The Melnyk grading 
system (2011) consists of seven levels with level I being the strongest and level VII being the 
weakest evidence.  The grading system is presented below in table 1.  
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Table 1:Hierarchy for Grading Data 
Level I Evidence from a systematic review or meta-analysis of all relevant 
RCTs 
Level II Evidence obtained from well-designed RCTs 
 
Level III Evidence obtained from well-designed controlled trials without 
randomization 
Level IV Evidence from well-designed case-control and cohort studies 
Level V Evidence from systematic reviews of descriptive and qualitative 
studies 
Level VI Evidence from single descriptive or qualitative studies 
Level VII Evidence from the opinion of authorities and/or reports of expert 
committees 
 
Note. Adapted from Evidence-based practice in nursing and healthcare: A guide to best practice, by Melnyk, B.M. 
& Fineout-Overholt, E., 2011, Philadelphia: Lippincott, Williams & Wilkins.   
 
The JBI grading of the evidence-based recommendation enables easy interpretation and 
implementation of the research evidences for both patients and clinicians into practice.  The new 
JBI grade of recommendation are adapted from the Grading of Recommendations Assessment, 
Development and Evaluation also known as the GRADE approach (The Joanna Briggs Institute, 
2014).  The GRADE approach provides supervision to grading the quality of the primary 
evidence and the strength of recommendations in health care (Brozek et al., 2009).  Unlike the 
level systems which classify findings based only on study design, the GRADE approach 
classifies research findings based on other factors such as “critical appraisal/risk of bias, 
publication bias, inconsistency, indirectness, and imprecision of evidence, effect size, dose-
response relationships, and confounders.” (The Joanna Briggs Institute, 2014, p. 3).  Thereby, 
randomized control trials study (Level I) may be ranked lower than a descriptive study (Level V 
or VI) or expert opinions (Level VII) when and where applicable (Brozek et al., 2009; The 
Joanna Briggs Institute, 2014).   
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The GRADE approach was created by Grade Working Group in 2000 and used to assist 
healthcare professionals with implementation of evidence into practice (Joanna Briggs Institute, 
2014).  The approach is now recognized by many evidence-based healthcare organizations such 
as Cochrane, World Health organizations (WHO), Agency for Healthcare Research and Quality 
(AHRQ), National Institute for Health and Care Excellence (NICE), British Medical Journal 
(BMJ) amongst others (The Joanna Briggs Institute (2014).  Furthermore, the GRADE 
recommendation approach suggested some vital factors such as the “balance between desirable 
and undesirable effects, the quality of the evidence, values and preferences, and costs” while 
developing recommendations (The Joanna Briggs Institute, 2014, p. 7).  The latest JBI binary 
grading system of recommendations adapted from GRADE contains two grading options: A 
“Strong” or “Weak” grade of recommendations with grade A being the strong recommendation, 
and Grade B representing a weak recommendation.         
Step Six:  Implementation Of The Evidence-Based Standard 
Based on the graded and the quality of the evidence, the recommendation emanated from 
these research evidences will be incorporated into the clinical practices according to clinical 
protocols and guidelines.  Officials from a local health network and the staff manager of a 
university student health center had expressed interested in this evidence-based 
recommendations.            
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Step Seven: Evaluation 
The seventh step of the IOWA EBP involves evaluation of the research evidence for 
success and possible modification. This phase also includes follow-up process to verify the 
efficacy of the evidence-based recommendation.  
Ethical Considerations 
This project is exempted from the Cedarville University IRB since there is no potential 
harm involved. 
Committee Members 
The committee consists of two members and one professional consultant:  
• Chu-Yu Huang, RN, PhD (Chair) 
• Elizabeth Delaney, MS, RN, CNS, FNP-BC, OCN, ACHPN (committee member)  
• Cliff Fawcett, M.S.N., M.Ed., RN, CFNP (professional consultant) 
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Chapter 4: Results 
 
Twenty-six articles were used to develop evidence-based recommendations for this 
project.  There were thirty six articles that met the inclusion criteria for this research project. Ten 
of the thirty six articles were excluded from the analysis due to the use of study participants from 
mixed age groups (such as a mix of middle school, high school and college students or 
adolescents with college populations and young adults) and limited evidence for managing 
prescription stimulants abuse.  However, two longitudinal study with mixed participants was 
retained for this project.  One of the longitudinal studies was designed as a randomized 
controlled trial.  However, both longitudinal studies provided descriptions of the effect of 
prescription drug abuse interventions introduced during adolescents on future initiation of 
substance abuse.   
The article selection process is presented in Figure 2.  Table 2 presents a summary of the 
results from the 26 articles.   
     
 
 
 
 
 
 
   
 
33 
 
Figure 2: Article Selection Process  
 
                                                             Screening  
 
 
 
                                                
                                                    Exclusion   
  
 
                                              
                                                  Eligibility 
      
 
 
 
 
 
 
 
 
 
36 Articles met 
inclusion 
criteria 
10 Articles removed due to 
mixed populations such as: 
• middle school, high 
school and college 
students 
• Adolescents 
populations with 
college students and 
young adults 
26 Articles Eligible 
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Table 2:Summary of Results from the Selected Articles 
Authors & Year 
published 
Research Titles  Design Results Level of 
Evidence 
Agency for 
Healthcare 
Research and 
Quality (2013) 
Attention deficit 
hyperactivity 
disorder. 
Diagnosis and 
management of 
ADHD in 
children, young 
people, and 
adults. 
Systematic 
Review 
People with ADHD require integrated 
care that addresses a wide range of 
personal, social, educational, and 
occupational needs.  
 
Care should be provided by 
adequately trained healthcare and 
educated professionals. 
 
ADHD with prescription stimulants 
need supervision 
 
Level I 
Amaro (2010)  Brief Screening 
and Intervention 
for Alcohol and 
Drug Use in a 
College Student 
Health Clinic: 
Feasibility, 
Implementation, 
and Outcomes.  
Descriptive 
Study 
Drinking and drug use decreased 
between baseline and 6 month after 
Brief Alcohol Screening Intervention 
for College Student (BASICS) 
program  
 
Alcohol use past 6 months before 
intervention: 
Baseline: 98.4%;  
6–months follow-up after 
intervention: 93.1% 
Chi-square value 14.3; p value 
(.0002) 
 
Heavy Episodic drinking past 6 
month before intervention: 
Baseline: 67.2% 
6-months follow-up after 
intervention: 50.3% 
Chi-square: 77.1; p<.0001  
 
Illicit drug use, past 6 months before 
intervention 
Baseline: 56.1% 
6-months follow-up after 
intervention: 51.0% 
Chi-square: 190.1: p <.0001 
 
Illegal use of prescription drugs 
(any), before intervention 
Baseline past 6 months before 
intervention 19.6% 
6-months follow-up after 
Level VI 
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intervention 16.9% 
Chi-square: 116.9 P<.0001 
 
At 6-month follow-up, college 
students reported decreases in the 
quantity and frequency of weekly 
episodic drinking (67% to 50%), 
decreases in alcohol or drug-use 
related distress and consequences, 
and reductions in illicit drug and 
prescription use.  
 
American 
College Health, 
(2007) 
Stimulant 
Misuse : 
Strategies to 
Manage a 
Growing 
Problem 
Expert opinion Recognize the existence of this 
problem; survey one’s campus 
environment 
 
Cooperation of university officials, 
health clinicians, college pharmacies, 
and local law enforcement officials  
 
Limit availability and access to 
prescription stimulants  
Educate high school and college 
students regarding the dangers of 
stimulant abuse  
 
Recognize signs of stimulant misuse 
and abuse and provide management 
options 
Level VII 
Arria, Caldeira, 
Vincent, Grady, 
& Wish (2008). 
Perceived 
Harmfulness 
Predicts 
Nonmedical Use 
of Prescription 
Drugs Among 
College 
Students: 
Interactions 
with Sensation-
Seeking 
 
A Longitudinal 
Descriptive 
Correlational 
Study 
High perceived harmfulness of PSA 
is associated with lower prevalence of 
nonmedical use of prescription 
stimulant use at all levels of 
sensation-seeking (p< 0.05).  
 
Individuals who perceived “no risk” 
in PSA were the most likely to use 
stimulants (b=3.4, p<0.01), followed 
by those whose perceived risk was 
“slight” (b=2.8, p<0.01) or 
“moderate” (b=0.9, p=0.11).  
 
 
Increasing perceived harmfulness 
may be a viable prevention strategy 
for most students 
 
 
Level VI 
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Baldwin, 
Johnson, Gotz, 
Wayment, & 
Elwell (2006). 
Perspectives of 
college students 
and their primary 
health care 
providers on 
substance abuse 
screening 
Exploratory 
descriptive 
Qualitative  
Face to face 
with focus 
group 
discussion 
 
 
1. There are inconsistences in 
substance abuse reported by the 
college students and the knowledge 
of their healthcare providers 
regarding the extent of substance use 
on college campus.   
 
2.Differences of opinions about who 
should bring up the topic of substance 
abuse in a college health care setting: 
• Providers recognized their 
critical role in bringing up the 
topic of substance abuse with 
their patients and felt 
responsible for creating an 
atmosphere of trust.  
• However, students prefer 
substance abuse be addressed 
by a psychologist or a 
counselor since substance 
abuse is a "mental issue.” 
• Substance abuse only 
becomes a doctor’s issue if it 
is health-related, such as if 
the provider is about to 
prescribe medication or if the 
patient is addicted to a 
substance. 
3. Difficulties in provider–patient 
communication reported by the 
healthcare provider and the student 
groups.  
• Providers stated 
awkwardness in provider–
patient communication about 
substance use. 
• Students were concerned 
about the confidentiality of 
information disclosed during 
an office visit and argued that 
they are afraid of negative 
judgment when disclosing a 
substance-abuse problem to a 
health-care provider in the 
university environment 
 
Level  VI 
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Barrett, 
Darredeau, 
Bordy, & Pihl 
(2005).   
Characteristics 
of 
Methylphenidate 
Misuse in a 
University 
Student Sample. 
Descriptive 
study 
 
 
Structured 
interviews  
 
  
• Methylphenidate (MPH) 
misusers reported using a 
greater variety of substances 
recreationally throughout 
their lifetimes (mean 7.7, SD 
3.0) relative to control 
subjects (mean 3.8, SD 3.1) 
{t = 5.98, df 98, P < 0.001).  
 
• Chi-square tests revealed that 
MPH users were more likely 
to report recreational use of 
ecstasy, cocaine, ephedrine, 
d-amphetamine, and 
psilocybin (all Ps < 0.001) 
than were control subjects. 
 
Level VI 
Barrett, 
Darredeau, Pihl 
(2006) 
Patterns of 
Simultaneous 
Polysubstance 
use in drug using 
university 
students  
Qualitative 
Descriptive 
study 
• Those who misused MPH 
were more likely to have 
used various other 
prescription and 
nonprescription stimulant 
drugs over their lifetimes,  
(mean 7.7, SD 3.0) relative to 
control subjects (mean 3.8, 
SD 3.1) {t = 5.98, df 98, P < 
0.001).  
• The Chi-square tests showed 
that MPH users were more 
likely to report recreational 
use of ecstasy, cocaine, 
ephedrine, d-amphetamine, 
and psilocybin (all Ps < 
0.001) than were control 
subjects 
• Chi-squared tests revealed 
that when alcohol was used 
in combination with any of 
cannabis, psilocybin, 
MDMA, cocaine, 
amphetamine, 
methylphenidate (ps<0.01) or 
LSD (p<0.05) its initial use 
preceded the administration 
of the other substance.  
• Paired samples t-tests 
revealed that when alcohol 
was used with cocaine 
(p<0.01) or methylphenidate 
(p<0.05) it was ingested in 
Level VI 
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greater quantities than when 
used in their absence. 
 
Bangert-Drowns 
(1988)  
The effects of 
school-based 
substance abuse 
education 
Meta-analysis 
 
Drug-related knowledge; 
Alcohol and drug education 
successfully increased drug-related 
knowledge, but was less successful in 
changing attitudes, and least 
successful in changing the drug-
related behaviors of students. 
Knowledge: t(25) = 6.83, p < .001 
Attitude, t(17) = 5.35, p < .001 
 
The average effect size for 
knowledge criteria was 0.76 standard 
deviations; 
attitude criteria: 0.34 standard 
deviations; 
Behavior criteria: 0.12 standard 
deviations.  
 
Only the knowledge and attitude 
effects were large enough to be 
reliably considered different from 
zero.  
The average effect for behavior was 
not significantly different from zero, t 
(13) = 1.23, p = .24. 
 
• Typical substance abuse 
education (focus on 
conventional alcohol and 
drug prevention) had its most 
positive effects on knowledge 
and attitudes, but was 
unsuccessful in changing the 
drug-using behaviors of 
students.   
 
Level I 
Espada, 
Gonzálvez, 
Lloret, Guillén-
Riquelme, 
Orgilés (2015)  
Meta-analysis of 
the effectiveness 
of school 
substance abuse 
prevention 
programs in 
Spain.  
Meta-analysis Oral and written substance abuse 
prevention program information 
together showed statistically 
significant results (d= 0.69; P<.01).  
 
The type of therapist implementing 
the program explained part of the 
variability as: the programs 
implemented by professionals alone 
(d= 0.25; p<.01) and those 
implemented by professionals and 
teachers together (d= 0.48; p<.01) 
Level 1 
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showed remarkable differences in 
effectiveness.  
 
Fachini, Aliane, 
Martinez, & 
Furtado, (2012) 
Efficacy of brief 
alcohol 
screening 
intervention for 
college students 
(BASICS)  
A meta-
analysis of 
randomized 
controlled 
trials.  
Overall, brief intervention for college 
students: (BASICS), delivered face-
to-face lowered both alcohol 
consumption and negative 
consequences in college students. 
 
At approximately 12 months, students 
receiving BASICS had 
a significant reduction in alcohol 
consumption (difference between 
means = −1.50 drinks per week, 95% 
CI: -3.24 to −0.29) and 
 Alcohol-related problems (difference 
between means = −0.87, 95% CI: -
1.58 to −0.20) compared to controls.  
 
On alcohol consumption: Q-statistics 
= 32.61, 11 df, p < .01). 
On alcohol related problems: Q-
statistics = 21.38, 10 df, p = .02. 
 
 
 
Brief intervention used “according to 
the principles of BASICS protocol or 
very similar one: 
(1) BI using techniques of 
motivational interview and 
personalized feedback,  
(2) face-to-face intervention, and 
(3) Comparison with other conditions 
(such as control group or alternative 
intervention).  
Level I 
Ford, & 
Schroeder, 
(2009).  
Academic strain 
and non-medical 
use of 
prescription 
stimulants 
among college 
students. 
Descriptive 
Correlational   
There is no direct connection between 
academic strain and stimulant use: 
Students who experience higher 
levels of academic strain should be 
more likely to report the presence of 
negative affect states. 
 
 In the structural model, academic 
strain 
is significantly associated with 
depression (Beta ¼ .070), as 
students under greater levels of 
academic strain are more 
likely to report higher levels of 
depression than respondents 
Level IV 
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who report lower levels of academic 
strain 
 
Students who report higher levels of 
depression are more likely to report 
the non-medical use of prescription 
stimulants  
Academic strain and depression in the 
past year .070*** 
Academic strain and stimulant use in 
the past year .001 
Academic strain and depression in the 
past 30days .192***  
Academic Strain and stimulant use in 
the past 30 days .002  
 
(Standardized parameter estimate as 
shown ***p < .001). 
 
 
 
Foxcroft (2014)   
  
  
Motivational 
interviewing 
(MI) for alcohol 
misuse in young 
adults. 
Randomized 
controlled trials  
 
At four or more months follow-up, 
effects were found for the quantity of 
alcohol consumed (standardized 
mean difference (SMD) 0.14; 95% 
confidence interval (CI) -0.20 to -
0.08 or a reduction from 13.7 
drinks/week to 12.2 drinks/week),  
Moderate quality of evidence;  
 
frequency of alcohol consumption 
(SMD -0.11; 95% CI -0.19 to -0.03 or 
a reduction in the number of 
days/week alcohol was consumed 
from2.74 days to 2.57 days),  
Moderate quality of evidence;  
Peak blood alcohol concentration 
(BAC) (SMD-0.14; 95%CI -0.23 to -
0.05 or a decrease in peak BAC 
from0.144%to 0.129%), 
Moderate quality of evidence.  
 
A marginal effect was found for 
alcohol problems (SMD -0.08; 95% 
CI -0.15 to 0.00 or a reduction in an 
alcohol problems scale score from 
8.91 to 8.18),  
Low quality of evidence. 
 
 No effects were found for binge 
drinking (SMD -0.05; 95% CI -0.12 
Level 1 
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to 0.01),  
Moderate quality of evidence;  
 
or average BAC (SMD -0.08; 95% CI 
-0.22 to 0.06),  
Moderate quality of evidence.  
 
Other outcomes and at four or more 
months follow-up we found no 
effects on drink-driving (SMD -0.11; 
95% CI -0.31 to 0.09),  
Moderate quality of evidence;  
 
or other alcohol-related risky 
behavior (SMD -0.14; 95% CI -0.30 
to 0.02), 
Moderate quality of evidence. 
 
Overall, no substantive, meaningful 
benefits of interventions for the 
prevention of alcohol Misuse 
 
Statistically Significant effects are 
not consistent for all misuse measures 
Although some significant effects 
were found, the effect sizes were 
interpreted as too small, given the 
measurement scales used in the 
studies included in the review, to be 
of relevance to policy or practice.  
 
Moreover, the statistically significant 
effects are not consistent for all 
misuse measures, heterogeneity was a 
problem in some analyses and bias 
cannot be discounted as a potential 
cause of these finding  
Herman, 
Shtayermman, 
Aksnes, 
Anzalone, 
Cormerais, & 
Liodice (2011).  
The Use of 
Prescription 
Stimulants to 
Enhance 
Academic 
Performance 
Among College 
Students in 
Health Care 
Programs.  
Cross-sectional, 
descriptive, and 
associational 
study  
Approximately 10.4% (32) of 
students surveyed have either used a 
stimulant or are currently using 
prescription stimulants illegally.  
 
The most common reason for 
stimulant use was to focus and 
concentrate during studying (93.5%).  
 
Of the 308 students, 45.2% were 
female, 83.9% were Caucasian, and 
amphetamine-dextroamphetamine 
was the most commonly abused 
stimulant (71.4%). 
Level VI 
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Demographic 
Race/ethnicity: 
Caucasians significant for nicotine 
dependence, Alcohol abuse p<.05, 
alcohol dependent p<.05, and drug 
dependence p<.001 
 
Male gender significant for alcohol 
dependence p<.05 
Female for nicotine dependence 
p<.001 
Asian demographic is significant for 
stimulant dependent p< .001 
Students in PA program also 
significant for nicotine dependence 
p< 0.001 compare to other 
professions such as RN, DO, PT and 
mental health counseling.  
 
Female for stimulant dependent 
Male for alcohol dependence p<.001 
 
 
Recommended substance abuse and 
awareness programs combined with 
stress management programs in an 
overall substance-abuse reduction 
strategy, including the use of 
prescription stimulant use beyond the 
originally intended purpose. 
 
Kazemi, Levine, 
Dmochowski, 
Nies, & Sun, 
(2013). 
Effects of 
Motivational 
Interviewing 
Intervention on 
Blackouts 
Among College 
Freshmen. 
Experimental  
Longitudinal 
study 
• The rate of blackouts 
decreased from 40% at 
baseline to 16% at six months 
(p < .0001). 
• The average number, time, 
and days of drinking and 
frequency of drug use 
decreased significantly (p < 
.0001). 
• MI had an impact on 
reducing alcohol 
consumption and the rate of 
blackouts among college 
freshmen who were engaging 
in high-risk drinking and 
illicit drug use. 
Level III 
Larimer, M. E., 
& Cronce, J. M. 
Identification, 
prevention, and 
Literature 
Review 
• No support was found for 
information/knowledge 
Level V 
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(2007).  treatment 
revisited: 
individual-
focused college 
drinking 
prevention 
strategies 1999-
2006.  
approaches alone, or for brief 
values clarification 
approaches alone or with 
other informational content.  
• Evidence was found in 
support of skills-based 
interventions and 
motivational interventions 
that incorporated 
personalized feedback, with 
or without an in-person 
intervention. Normative re-
education interventions 
received mixed support 
though personalized 
normative feedback was 
associated with positive 
outcomes. 
Looby, De 
Young, & 
Earleywine, 
(2013).   
Challenging 
expectancies to 
prevent 
nonmedical 
prescription 
stimulant use. 
Randomized 
Control Trials  
The expectancy challenge 
successfully modified expectancies 
related to prescription stimulant 
effects. 
 
19% of the total sample reported 
initiation of non-medical use of 
prescription stimulant by follow-up.  
 
Nearly all individuals who (17/18) 
who reported non-medical use 
attributed their use to cognitive 
enhancement and study assistance 
motivations.  
Level 1 
Mason, Deane,  
Kelly, Peter, & 
Crowe (2009). 
Do Help in the 
Management of 
Cravings in 
Substance Abuse 
Treatment? 
Descriptive 
Cross -sectional 
study with 
interview 
Spirituality and self-efficacy have 
significant relationships with cravings 
 
Self-efficacy mediated the 
relationship between spirituality and 
drug and/or alcohol cravings 
 
There were positive correlations 
found between spirituality and self- 
efficacy 
 (r = .33) and spirituality and 
religiosity (r = .69). 
 
 
Spirituality has a significant 
influence on “cravings” 
(β =–.33, p =.04). 
 
A statistically significant inverse 
Level VI 
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relationship was found between 
“cravings” and spirituality (r = –.30) 
No significant effect for the influence 
of religiosity on “cravings” (β = .05, 
p = .75). 
 
Self-efficacy had a significant 
influence on “cravings” (β = –.34, p 
= .01) 
 
Self-efficacy was negatively 
correlated with “cravings” 
 (r = –.42). 
 
The R2 suggests that spirituality and 
religion account for 8.9% of the 
variance in “cravings.”  
 
 
McCabe & Teter 
(2007) 
Drug use related 
problems among 
nonmedical 
users of 
prescription 
stimulants:  
Descriptive 
Qualitative  
Increase in simultaneous poly-drug 
use occurs among college students 
with NMUPS than other drug users 
(53.8% versus 16.9%, p<0.001) 
 
Past year medical users of 
prescription stimulants will 
experience blackouts as a result of 
drug use (21.7% versus 8.3%, 
p<0.001), engaged in illegal activities 
to obtain drugs (27.4% versus 9.3%, 
p<0.001), and experienced 
withdrawal symptoms when they 
stopped taking drugs (14.6% versus 
2.5%, p<0.001) than other drug users. 
 
The frequency of (nonmedical use 
prescription stimulants) NMUPS was 
associated with drug use related 
problems based on the (Drug Abuse 
Screen Test (DAST-10).  
 
Among past-year non- medical users 
of prescription stimulants (n=212), 
experiencing three or more DAST-10 
items was reported by 42.2% of those 
who used on 1 to 2 occasions,  
58.2% (3 to 5 occasions),  
58.3% (6 to 9occasions), 
and76.3% of those who used on 10 or 
more occasions (χ2 =12.9, df=3, 
p<0.01). 
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Majority of nonmedical users of 
prescription stimulants are polydrug 
users and should be screened for 
potential drug abuse or dependence, 
especially those who report non-oral 
routes of administration. 
Redman (2008). Stressful life 
experiences and 
the roles of 
spirituality 
among people 
with a history of 
substance abuse 
and 
incarceration.  
Qualitative 
Descriptive 
 
  
Eight themes emerged from the study 
regarding the roles that spirituality 
played in the study participants’ lives, 
including utilizing spirituality to: 
1. Seek a context for adversity 
in order to better cope with 
its impact; described 
combing through religious 
and spiritual texts for 
passages that might help 
them understand and cope 
with the anguish they had 
experienced. 
2. Using a spiritual framework 
to understand one’s own true 
nature: These men and 
women reported reading 
spiritual tracts, seeking 
guidance from religious or 
spiritual leaders, praying for 
answers, meditating, or 
engaging in other spiritual 
practices in an effort to gain 
greater perspective on their 
authentic selves. 
Approximately 20% of the 
respondents asserted that 
accessing explicit spiritual 
guidance seemed preferable 
to traditional mental health-
related therapy or counseling 
3. Seek redemption for past 
transgressions; more than 
90% of the respondents 
expressed remorse over the 
harm they had inflicted 
through negligence, anger, or 
exploitation. They voiced the 
hope that a divine being 
might be able to redeem them 
for the pain they had 
engendered. 
4. Redeem, care for, or liberate 
others; One- third expressed 
Level IV 
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a more generalized wish to 
allow God or some 
transcendent spirit to work 
through them in acts of 
kindness, compassion, and 
caring for others. 
5. repay the debt of having 
one’s life saved by divine 
intervention; A quarter of the 
respondents posited that, 
after facing one potentially 
fatal situation after another, 
their lives had been spared by 
divine intervention, and they 
needed to repay that debt. 
6. Develop a relationship with a 
divine entity as human beings 
have proven untrustworthy; 
Nineteen percent of the 
respondents utilizing 
spirituality as a shaping force 
in their lives explained that, 
subsequent to the many 
disappointments and 
betrayals they had endured at 
the hands of others, God was 
all they could count on. And, 
deepening their relationships 
with God would provide the 
intimacy and trust that was 
lacking in their connection 
with other human beings.  
7. Utilizing spirituality to 
modify the use of drugs and 
or alcohol; More than half of 
the respondents associated 
spirituality with abstinence or 
a modification of substance 
use and some link abstinence 
with relationship with God 
and  
8. Transform one’s character: 
turned to God for assistance 
in changing his attitudes 
about himself and others: 
About 36 % articulated the 
theme of spirituality as a 
route to self- transformation. 
They hope that based on the 
changes wrought with God’s 
assistance, they would lead a 
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more positive and productive 
life. 
 
Sarkar, 
Balachander, & 
Basu (2014). 
Perceived 
Harmfulness of 
Substance Use 
Descriptive 
Qualitative  
Greater degree of education was 
associated with lower harm rankings 
for 
heroin, cannabis, 
dextropropoxyphene, and raw opium 
 
Urban residence was associated with 
greater harm ratings for cannabis and 
raw opium.  
 
Differences in the harms were 
perceived for different preparations 
of the same active compound for 
alcohol and nicotine.  
 
Harm ratings of substances can be a 
useful guide while formulating 
policies and allocating resources. 
Level VI 
Saitz, Barrio, & 
Miquel (2014). 
Screening and 
brief 
intervention 
(SBI) for 
Unhealthy drug 
use: little or no 
efficacy.  
Literature  
Review  
• Evidence now suggests that 
efficacy is limited or non-
existent. 
• Brief intervention may have 
some efficacy for unhealthy 
drug users seeking help. 
• The model of SBI that has 
effects in primary care 
settings on risky alcohol use 
may not be efficacious for 
other drug use 
Level V 
Spoth, Trudeau, 
Guyll, Shin, & 
Redmond (2009) 
Universal 
Intervention 
Effects on 
Substance Use 
Among Young 
Adults Mediated 
by Delayed 
Adolescent 
Substance 
Initiation 
Experimental 
longitudinal 
study  
 
Universal family focused 
intervention: Iowa Strengthening 
Family program (ISFP) and Preparing 
for the Drug-Free Years (PDFY) 
were implemented 
 
 
There is a significant (p< .05) Iowa 
Strengthening Family program (ISFP) 
direct effects on drunkenness 
frequency and the Polysubstance Use 
Index, and a marginally significant 
(p<.10) ISFP direct effect on cigarette 
frequency.  
 
There is a significant direct Preparing 
for the Drug-Free Years (PDFY) 
effects on cigarette frequency and 
Level III 
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alcohol-related problems (p<.05).  
 
Initiating Universal family-focused 
interventions (ISFP and PDFY: 
prevention programs) for delayed 
substance use during adolescence can 
reduce problematic substance use 
during young adulthood 
 
 
Relative reduction rates (RRR)  
ranged from 19% to 31% for ISFP 
and from 9% to 16% for PDFY 
 
Early intervention of substance abuse 
prevention program such as universal 
intervention may reduce substance 
abuse during young adulthood. 
Spoth, Trudeau, 
Shin, Ralston, 
Redmond, 
Greenberg, & 
Feinberg, (2013)
  
 
Longitudinal 
Effects of 
Universal 
Preventive 
Intervention 
on Prescription 
Drug Misuse 
 With Late 
Adolescents and 
Young Adults 
 
Randomized 
Controlled 
Trials (RCT) to 
evaluate Iowa 
Strengthening 
Families 
program (SFP) 
for parents and 
youth 10-14 
years (SFP 10-
14) and Life 
Skill Training 
(LST) 
 
Study One 
The Iowa SFP reduces prescription 
opioid misuse (POM) and 
prescription drug misuse overall 
(PDMO). 
(Relative reduction rates (RRR): age 
25 years of 65%, and comparable 
benefits for higher and lower risk 
subgroups   
Study Two 
The IOWA SFP 10–14 + LST 
showed significant or marginally 
significant effects on POM and 
PDMO across all ages (21, 22, and 25 
years); higher-risk participants 
showed stronger effects (RRRs = 
32%–79%) 
Study 3 
 Shows significant results for POM 
and PDMO (12th grade RRRs = 
20%–21%); higher-risk and lower-
risk participants showed comparable 
outcomes. 
Level 1 
Treloar, 
Dubreuil, & 
Miranda JR., 
(2014) 
Spirituality and 
Treatment of 
Addictive 
Disorders. 
Experts 
opinions 
Since multicultural competence can 
increase the ability of health care 
providers to work effectively with 
culturally diverse populations, 
spiritual competence among health 
care providers may enhance their 
effectiveness when working with 
individuals struggling with 
addictions. 
 
Level VII 
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Effective interventions such as 
Motivational Interviewing and 
Acceptance and Commitment 
Therapy acknowledge the importance 
of the provider’s ability to allow a 
creation of an open, non-judgmental 
and compassionate environment. 
 
When working in the area of 
addiction treatment, spiritual 
competence may increase the ability 
of the provider to help the client to 
discover or rediscover their own 
purpose and core values, explore the 
negative consequences of the 
addictive behavior on these values, 
and to develop behaviors that support 
the identified core values.  
 
If the provider has not considered his 
or her own spiritual competence, or 
moreover, holds the view that 
spiritual competence is not important 
for treatment, he or she may be less 
able to recognize or attend to the 
client’s needs or perspectives. 
 
 
 
 
 
Spirituality plays a vital role in the 
development and recovery of 
addictive disorders. However, health 
care professionals need Spiritual 
competences.  
 
 
Weyandt, Oster, 
Marraccini, 
Gudmundsdottir 
Munro, 
Martinez 
Zavras, & Kuhar 
(2014).  
Pharmacological 
interventions for 
Pharmacology 
intervention for 
adolescents and 
adults with 
ADHD: 
stimulant and 
non-stimulant 
medications and 
misuse of 
prescription 
stimulants.  
Systematic 
Review 
• Both prostimulant and 
stimulant medications, such 
as lisdexamfetamine 
dimesylate, methylphenidate, 
amphetamines, and mixed-
amphetamine salts, are 
effective in reducing ADHD 
symptoms in adolescents and 
adults with ADHD. 
• Individuals with ADHD may 
have higher rates of stimulant 
misuse than individuals 
Level II 
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without the disorder. 
• Characteristics such as sex, 
race, use of illicit drugs, and 
academic performance are 
associated with misuse of 
stimulant medications. 
• Individuals both with and 
without ADHD are more 
likely to misuse short-acting 
agents than long-acting 
agents. 
Young, Stevens, 
Galipeau, Pirie, 
Garritty, Singh, 
Yazdi, Golfam, 
Pratt, Turner, 
Porath,-waller, 
Arratoon, Haley, 
Leslie, Reardon, 
Sproule, 
Grimshaw, 
Moher (2014).  
 
Effectiveness of 
brief 
interventions as 
part of the 
Screening, Brief 
Intervention and 
Referral to 
Treatment 
(SBIRT) model 
for reducing the 
nonmedical use 
of psychoactive 
substances:  
Systematic 
review 
Insufficient evidence exists as to 
whether BIs, as part of SBIRT, are 
effective or ineffective for reducing 
the use of, or harms associated with 
nonmedical use of, psychoactive 
substances when these interventions 
are administered to non -treatment-
seeking, screen-detected populations.  
Level I 
 
Summary of Findings 
Strengths of evidence.  A summary of the levels of evidence of the 26 articles is 
presented in Table 3. The strength of the research evidences of these studies ranges from level I 
to level VII.  The most commonly used research designs were systematic review/meta-analysis 
or single descriptive/qualitative studies.  Eight studies were level I (systematic review or meta-
analysis of all relevant RCTs) (30.8%) and eight studies were level VI (30.8-%).  Another 
common research findings in the project are level III (7.7%), level IV (7.7%) and level VII 
(7.7%). The rest of the research designs also include level IV (11.5%) and level II (3.8%).  The 
longitudinal studies in this project revealed the effect of early substance abuse prevention 
program which was initiated during early adolescent’s stage to monitor the participants’ 
behaviors towards substance abuse through young adulthood (Spoth, Trudeau, Guyll et al., 2009; 
Spoth, Trudeau, Shin et al., 2013).  Spoth, Trudeau, Shin et al. (2013) research study shows the 
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effect of universal prevention intervention initiated during early adolescents, and participants’ 
behavior towards substance abuse was monitored through late adolescents, college and young 
adulthood.  One of the expert opinions research designs (level VII) addressed spirituality in 
relation to substance disorders while the other design from the American college Health 
recognized the need and suggested ways to manage the problems of increasing prescription 
stimulant abuse among all students including high schools’.  
Table 3:Summary: Levels of Evidence 
Level Types of Evidence Number/Percentage of 
Studies in This Project 
Level I Evidence from a systematic review or meta-
analysis of all relevant RCTs 
8 (30.8%) 
Level II Evidence obtained from well-designed RCTs 
 
1 (3.8%) 
Level III Evidence obtained from well-designed controlled 
trials without randomization 
2 (7.7%) 
Level IV Evidence from well-designed case-control and 
cohort studies 
3 (11.5%) 
Level V Evidence from systematic reviews of descriptive 
and qualitative studies 
2 (7.7%) 
Level VI Evidence from single descriptive or qualitative 
studies 
8 (30.8%) 
Level VII Evidence from the opinion of authorities and/or 
reports of expert committees 
2 (7.7%) 
 
Note. Adapted from Evidence-based practice in nursing and healthcare: A guide to best practice, by Melnyk, B.M. 
& Fineout-Overholt, E., 2011, Philadelphia: Lippincott, Williams & Wilkins.   
 
          General findings about PSA.  Despite being the most widely misused prescription drugs 
among college students, prescriptions stimulants have been accepted as non-dangerous as long as 
they are dispensed as ordered, used as prescribed, and closely monitored by licensed 
professionals (Agency for Health care Research and Quality, 2013; Weyandt et al., 2014).  
Nevertheless, individuals both with and without ADHD symptoms who use prescription 
stimulants such as Adderall, Ritalin, Concerta, and Vyvanse have been revealed as more likely to 
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misuse the stimulants (Weyandt et al., 2014).  Furthermore, college students’ perception of 
prescription stimulants “as opposed to illegal stimulants (cocaine and methamphetamine) as 
“safer and pure choices” for experimentation and getting high puts them at a higher risk for 
stimulant abuse than any populations (Cutler, 2014, p. 278; Herman et al., 2011).  McCabe, 
Knight, Teter et al. (2005) revealed the lifetime prevalence of prescription stimulant use in 2001 
among college students as 6.9-percent with higher rate among colleges located in the north-
eastern region of the US and colleges with more competitive admission standards.  In addition, 
the result of the survey conducted by McCabe, West and colleagues in 2014, revealed the past 
year illegal use of stimulants among college students has a significant increase from 5.4% in 
2003 to 9.3% in 2013 (p<0.001).  The result of the survey also disclosed approximately one in 
every five individuals reported non-medical use of at least one prescription medication class in 
their lifetime.  The probabilities of non-medical use of each prescription medication class were 
generally greater among males, Whites, members of social fraternities and sororities, and those 
with a lifetime history of medical use of prescription medications or a past-year history of being 
approached to divert their prescription medications (McCabe, Knight, Teter et al., 2005 & 
McCabe, West, Teter et al., 2014).  Therefore, the increase in awareness and education with 
prescription stimulant abuse competence for the providers and college students are very crucial 
to the management of PSA among college students.  
         Most college students are unaware of the dangers associated with the use of prescription 
stimulants without the supervision of a license health care provider (Arria et al., 2008; Baldwin 
et al., 2006).  One of the problems associated with PSA or any psycho-stimulant abuse is the 
problem of poly-substance abuse which increases with prescription stimulant use and abuse 
(Barrett, Darredeau, Bordy et al, 2005; Barrett, Darredeau, Pihl, 2006).  Several studies have 
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revealed alcohol, nicotine and marijuana as access drugs to other psycho-stimulant abuse 
(Barrett, Darredeau, Pihl, 2006; DeSantis, Webb et al., 2008; DeSantis, Noar et al, 2010; 
Johnston et al, 2013).  At the same time, the risk of misusing prescription stimulants increases 
with college students who smoke and abuse alcohol than other drug users.  A study by McCabe 
& Teter, 2007) revealed increase in simultaneous poly-drug use occurs among college students 
with NMUPS than other drug users (53.8% versus 16.9%, p<0.001) (McCabe & Teter, 2007).  
The increasing number of students who abuse prescription stimulant suggest lack of awareness 
and education about the dangers and health related consequences of PSA.  Therefore, increasing 
perceived harmfulness through awareness and education has been suggested as a possible 
prevention strategy for most college students (Agency for Health care research and Quality, 
2013; American College Health, 2007; Arria et al., 2008; Baldwin et al., 2006; Bangert-Drowns, 
2014; Herman et al., 2011; Sarkar et al., 2014).  In 2011, Herman and colleagues’s study also 
revealed the impact of academic stress among college students who abuse prescription 
stimulants.  The study revealed approximately 10.4-percent of the students surveyed have either 
used a stimulant or are currently using prescription stimulants illegally.  The most common 
reason for stimulant use was to focus and concentrate during studying (93.5%).  Of the 308 
students, 45.2% were female, 83.9% were Caucasian, and amphetamine-dextroamphetamine was 
the most commonly abused stimulant (71.4%).   Moreover, ineffective coping skills with life 
events and academic enhancement are among the motives identified by some college students.  
DeSantis, Webb, & Noar (2008), survey shows most students who are unable to cope with the 
workload of college use stimulants for academic performance enhancement.  However, the study 
by Mason et al (2009) showed self-efficacy- a mediator between spirituality and drug/or alcohol 
cravings as part of stress management reduction program.  According to Bandura, (1986), self-
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efficacy is defined as an individual’s belief that he or she can successfully manage or cope with 
difficult situations.  Therefore, several studies have recommended stress management programs 
in an overall substance-abuse reduction strategy including the use of prescription stimulant abuse 
(Herman et al., 2011; Mason et al., 2009; Redman, 2008). 
Interventions/management.  Four studies investigated effectiveness of universal 
prevention interventions programs for general substance abuse such as school based and 
community based substance prevention program (Banger-Drowns, 1988; Espada, 2015; Spoth, 
Trudeau et al., 2009; Spoth, Trudeau, Shin, Ralston et al., 2013).  The key aspects of the findings 
in this project are:  
• Collaborative approach of interventions (such as community university collaboration) 
(Baldwin et al., 2008; Espada et al., 2015).  Research findings suggested 
collaboration between healthcare providers and the community such as schools in 
implementing overall substance abuse prevention program.Family involvement 
intervention (Spoth, Trudeau et al., 2009; Spoth, Trudeau, Shin, Ralston et al., 2013). 
• Studies have shown the effectiveness of universal preventive intervention program 
such as family-focused and school-based interventions in the management of youth 
risk-taking behaviors such as alcohol abuse and other substance abuse behavior 
problems (Spoth, Guyll, Trudeau et al., 2002; Spoth, Trudeau, Guyll, Shin et al., 
2009; Spoth,  Trudeau, Shin, Ralston et al., 2013).  Family strengthening program has 
been suggested as the treatment with the strongest evidence of relative effectiveness 
(Level 1 evidence).  Family therapy programs were found to be more effective than 
their comparison conditions and, no treatment programs were less effective.  In 
addition, the longitudinal study by Spoth, Trudeau et al. (2014) revealed all types of 
   
 
55 
treatment such as the Preparing for Drug Free Year (PDFY) and Iowa Strengthening 
Family Program  (ISFP) showed reductions in substance use and the greatest 
improvements were found for family therapy and mixed and group counseling.  
Moreover, the result of Spoth, Trudeau, Guyill et al (2009) showed a significant ( p< 
.05) Iowa Strengthening Family program (ISFP) direct effects on drunkenness 
frequency and the polysubstance use index, and a marginally significant (p<.10) ISFP 
direct effect on cigarette frequency and alcohol-related problems (p<.05). 
     Significance of raising awareness through educational/training/screening programs (Agency 
for Healthcare Research and Quality, 2013; Arria et al., 2008; American college Health, 2007; 
Amaro, 2010; Barrett, Darredeau, Pihl, 2006; Barrett, Darredeau, Bordy et al., 2005; Foxcroft, 
2014; Kazemi, et al., 2013; Larimer et al., 2007; McCabe & Teter, 2007; Sarkar et al., 2014; 
Saitz et al., 2014; Young et al., 2014).  The research findings from Arria and colleagues (2008) 
revealed awareness through education as one of the most crucial ways to manage prescription 
stimulants abuse among college students.  Baldwin and colleagues study revealed most providers 
lack of awareness of the prevalence of misuse of prescription drugs especially prescription 
stimulants among the college students.  Healthcare providers caring for college students with 
prescription stimulants need to improve continuously in substance abuse management 
competency (Baldwin et al., 2006; Agency for Healthcare Research and Quality, 2013).  
Likewise, college students need to be educated on the prescription medication they are using 
(Baldwin et al., 2006; Agency for Healthcare Research and Quality, 2013).   
Spirituality:  The expert opinion regarding spirituality in the management of overall 
substance abuse should not be ignored (Treloar et al, 2014).  Spiritual competence has been 
suggested for health care providers to improve their Spirituality and provide effective 
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substance abuse intervention programs while working with individuals struggling with 
addictions (Treloar, 2014).  Redman (2008) study shows the meaning of Spirituality is 
different with individuals.  However, developing Spiritual competence may assist the health 
care providers to be sensitive, recognize and attend to the underlying problems and needs of 
the patients with addiction (Redman, 2008).  Treloar (2014) concluded that Spirituality plays 
a vital role in the growth and recovery of addictive disorders. However, health care 
professionals need Spiritual competences.    
Evidence-Based Recommendations 
 
  Strong Recommendations (GRADE A) 
1. The primary health care provider should pursue increase in knowledge/ awareness with 
periodic education and training regarding prescription stimulants to ensure proper and 
safe prescription stimulant use and reduce diversion among college students (Level I: 
Agency for Healthcare Research and Quality, 2013; Arrial et al., 2008; Bangert-
Drowns, 1988;  Espada et al., 2015;  Level VI: Baldwin et al., 2006). 
2. The health care provider should initiate substance abuse prevention in primary care that 
includes brief screening, and motivational intervention. A necessity for feedbacks and 
subsequent follow-ups should also be communicated to the college students (Level VI: 
Amaro, 2010; Level 1: Fachini et al. 2012; Level V: Kazemi et el., 2013). 
3. The health care provider should provide comprehensive information including major 
health-related harmful effects of prescription stimulant abuse to college student with 
ADHD symptoms who requires the use of prescription stimulants (Level IV: Arria et 
al., 2008; Level IV: Barrett, Darredeau, Pihl., 2006; MCabe et al., 2007). 
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4. The health care provider should provide information regarding poly-substance abuse 
for college students who use prescription stimulant.  Moreover, the healthcare provider 
should consider screening college students with prescription stimulant for poly- 
substance abuse (Level IV: Barrett, Darredeau, Bordy et al., 2005; Barrett, Darredeau, 
Pihl, 2006; McCabe, West, Morales et al., 2007). 
5. The health care providers should encourage parents of college students to take a 
primary role in understanding the need for family involvement in the prevention of 
nonmedical use of prescription stimulants (Level of evidence VI: Spoth, Trudeau et al., 
2009; Level I: Spoth, Trudeau, Shin et al., 2013). 
6. The health care providers should work with college student campus administrations to 
implement appropriate school-based substance prevention program and develop a 
multidisciplinary campus action plans and community collaboration to reduce 
nonmedical prescription stimulant use as was implemented with smoking and other 
illicit drugs (Level of Evidence VI: Baldwin et al., 2006; Level of Evidence 1: Espada, 
2015).  
Weak Recommendation (GRADE B) 
1. The health care provider may consider offering spiritual support programs as substance 
abuse prevention program based on college students' cultures and beliefs ( Level IV: 
Mason et al., 2009: Level VII: Redman, 2008; Treloar et al., 2014).  
2. The health care provider may provide awareness programs combined with stress 
management programs in an overall substance-abuse reduction strategy, including the use 
of prescription stimulant beyond the originally intended purpose (Level of Evidence IV: 
Ford et al., 2009; Level VI  Herman et al., 2011) 
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Chapter 5: Discussion 
 
College students have been identified as one of the populations with a tendency to abuse 
prescription stimulants.  Evidence-based recommendations were developed in this project to 
assist healthcare providers in the management of PSA among college students.  These 
recommendations will serve as a guiding tool when caring for college students with ADHD, or 
college students with potential for prescription stimulant abuse.  Moreover, these 
recommendations may be used in primary care settings that care for college students or young 
adults with a history of prescription stimulant/substance abuse and contemplate on quitting.    
Gough (2001) stated a change implemented by front-lines practitioners such as primary care 
providers is more successful than the one initiated by the management.  Health care providers 
occupy several roles in the society such as a teacher, mentor, and guardian.  Understanding the 
importance of managing prescription stimulant abuse to make positive changes that may lower 
the prevalence of PSA is crucial to health care provider’s role.  Initiating substance prevention 
interventions such as awareness, family strengthening among others earlier in life before 
attending college may be more beneficial in reducing the tendency to engage in PSA later in life.  
Nevertheless, providing awareness and education for college students and family regarding the 
prevalence of subsance abuse in general is crucial to reducing prescription stimulant abuse 
among college students (Arria et al., 2008: Agency or Healthcare Research and Quality, 2013; 
Bangert-Drown, 1988) ( also see Appendix).  At the same time, healthcare providers must be 
knowledgeable, experienced and comfortable to address the issues which surround PSA among 
college students (Baldwin, 2006). 
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